
Monday, July 29, 2024 8:21:09 PM
TLPH. New mission … to get a drug used in Korea and Japan approved in the US
From memory- heparin is used in dialysis to prevent clotting … it has a fairly long half life
The problem is those admitted to the ICU after surgery or from a serious accident and need dialysis …. Need something that prevents clotting but only for a short time … as these patients often have high bleeding risk
That’s what TLPH’s drug does …. Reduces clotting for a short time
FDA requires a US trial before approval
Problem … since Covid a lot of the hospital staff that set up these trials have retired
So it’s been slow to get this pivotal trial going But looks like it may finally be underway
So either that or more funding
JMO
Kiwi
Recent TLPH News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 04/17/2025 08:30:50 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/03/2025 09:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2025 08:31:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2025 08:29:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2025 08:28:23 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/03/2025 01:59:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2025 09:09:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:01:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2025 08:11:39 PM
- Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 03/31/2025 08:05:00 PM
- Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million • PR Newswire (US) • 03/31/2025 12:30:00 PM
- Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025 • PR Newswire (US) • 03/26/2025 08:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2025 11:52:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 09:49:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 09:47:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2025 09:09:30 PM
- Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study • PR Newswire (US) • 01/14/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 09:31:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 11:05:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 09:22:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 09:20:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2024 05:31:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 09:30:26 PM
- Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors • PR Newswire (US) • 11/25/2024 12:27:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 10:15:14 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM
UAV Corp Names David Dugas as President and Chief Operating Officer • UMAV • Apr 17, 2025 8:30 AM
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus • YCRM • Apr 16, 2025 11:07 AM
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit • AVAI • Apr 16, 2025 8:00 AM
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers • HLYK • Apr 14, 2025 8:00 AM
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center • GDLG • Apr 10, 2025 4:00 PM